4.8 Article

Protein-altering and regulatory genetic variants near GATA4 implicated in bicuspid aortic valve

Journal

NATURE COMMUNICATIONS
Volume 8, Issue -, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/ncomms15481

Keywords

-

Funding

  1. FCVC
  2. Aikens Fund for Aortic Research
  3. McKay research award
  4. American Association of Thoracic Surgery (AATS) Graham Foundation
  5. Thoracic Surgery Foundation of Research and Education (TSFRE)
  6. Doris Duke Charitable Foundation [2013104, HL122684]
  7. Danish Heart Foundation
  8. Lundbeck Foundation
  9. A.P. Moller Foundation for the Advancement of Medical Science
  10. MHI Foundation
  11. Canada Research Chair Program
  12. Leducq Foundation (MIBAVA)
  13. Andrea and Charles Bronfman Philanthropies
  14. NIH [NHGRI U01HG007417]
  15. Common Fund of the Office of the Director of the National Institutes of Health
  16. NCI
  17. NHGRI
  18. NHLBI
  19. NIDA
  20. NIMH
  21. NINDS
  22. Broad Institute [HHSN268201000029C]
  23. van Andel Institute [10ST1035, HHSN261200800001E]
  24. University of Miami [DA006227, DA033684, N01MH000028]
  25. University of Geneva [MH090941, MH101814]
  26. University of Chicago [MH090951, MH090937, MH101820, MH101825]
  27. University of North Carolina-Chapel Hill [MH090936, MH101819]
  28. Harvard University [MH090948]
  29. Stanford University [MH101782]
  30. Washington University St Louis [MH101810]
  31. University of Pennsylvania [MH101822]
  32. [HL109946]
  33. [HL130705]
  34. [HL127564]
  35. [HL114823]

Ask authors/readers for more resources

Bicuspid aortic valve (BAV) is a heritable congenital heart defect and an important risk factor for valvulopathy and aortopathy. Here we report a genome-wide association scan of 466 BAV cases and 4,660 age, sex and ethnicity-matched controls with replication in up to 1,326 cases and 8,103 controls. We identify association with a noncoding variant 151 kb from the gene encoding the cardiac-specific transcription factor, GATA4, and near-significance for p.Ser377Gly in GATA4. GATA4 was interrupted by CRISPR-Cas9 in induced pluripotent stem cells from healthy donors. The disruption of GATA4 significantly impaired the transition from endothelial cells into mesenchymal cells, a critical step in heart valve development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available